New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Caraco Pharmaceutical Laboratories (CPD)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-DEC
2009
31-MAR
2010
30-JUN
2010
30-SEP
2010
31-DEC
2010
Total Revenue
52.0M
55.2M
130M
97.8M
40.4M
Cost of Revenue
47.8M
65.8M
119M
87.1M
35.9M
Gross Profit
4.22M
-10.6M
10.7M
10.7M
4.53M
Research & Development
2.75M
1.77M
2.12M
3.98M
1.73M
SG&A
5.40M
6.91M
5.84M
7.97M
6.59M
Amortization & Deprec
1.14M
1.12M
1.19M
1.20M
1.21M
Other Expenses
-200K
-482K
-499K
-334K
-186K
Total Operating Expenses
9.09M
9.33M
8.65M
12.8M
9.34M
Operating Income
-4.87M
-19.9M
2.08M
-2.12M
-4.81M
Other Income
74.4K
16.0M
0
2500
8354
EBIT
-4.80M
-3.91M
2.08M
-2.11M
-4.80M
Minority Interest
0
0
0
0
0
Interest Expense
144K
465K
198K
180K
18.6K
Income Before Taxes
-4.94M
-4.38M
1.88M
-2.29M
-4.82M
Income Taxes
-1.91M
-1.51M
673K
-786K
-1.78M
Net Income from Continuing Ops
-3.03M
-2.87M
1.21M
-1.51M
-3.04M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-3.03M
-2.87M
1.21M
-1.51M
-3.04M
Preferred Dividends
0
0
0
0
0
Net Income to Common
-3.03M
-2.87M
1.21M
-1.51M
-3.04M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour